Literature DB >> 24488332

Case of Shigella flexneri infection with treatment failure due to azithromycin resistance in an HIV-positive patient.

R-J Hassing1, D C Melles, W H F Goessens, B J A Rijnders.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24488332     DOI: 10.1007/s15010-014-0594-4

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


× No keyword cloud information.
  6 in total

1.  Shigellosis in Bay of Bengal Islands, India: clinical and seasonal patterns, surveillance of antibiotic susceptibility patterns, and molecular characterization of multidrug-resistant Shigella strains isolated during a 6-year period from 2006 to 2011.

Authors:  D Bhattacharya; H Bhattacharya; R Thamizhmani; D S Sayi; R Reesu; M Anwesh; C Kartick; A P Bharadwaj; M Singhania; A P Sugunan; S Roy
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-08-29       Impact factor: 3.267

2.  Reduced azithromycin susceptibility in Shigella sonnei, United States.

Authors:  Rebecca Leigh Howie; Jason P Folster; Anna Bowen; Ezra J Barzilay; Jean M Whichard
Journal:  Microb Drug Resist       Date:  2010-07-12       Impact factor: 3.431

3.  Outbreak of infections caused by Shigella sonnei with reduced susceptibility to azithromycin in the United States.

Authors:  Maria Sjölund Karlsson; Anna Bowen; Roshan Reporter; Jason P Folster; Julian E Grass; Rebecca L Howie; Julia Taylor; Jean M Whichard
Journal:  Antimicrob Agents Chemother       Date:  2012-12-28       Impact factor: 5.191

4.  Systemic shigellosis in South Africa.

Authors:  Karen H Keddy; Arvinda Sooka; Penny Crowther-Gibson; Vanessa Quan; Susan Meiring; Cheryl Cohen; Trusha Nana; Charlotte Sriruttan; Sharona Seetharam; Anwar Hoosen; Preneshni Naicker; Eugenne Elliott; Sumayya Haffejee; Andrew Whitelaw; Keith P Klugman
Journal:  Clin Infect Dis       Date:  2012-04-03       Impact factor: 9.079

5.  High rates of quinolone-resistant strains of Shigella sonnei in HIV-infected MSM.

Authors:  C Hoffmann; H Sahly; A Jessen; P Ingiliz; H-J Stellbrink; S Neifer; K Schewe; S Dupke; A Baumgarten; A Kuschel; I Krznaric
Journal:  Infection       Date:  2013-07-13       Impact factor: 3.553

6.  HIV infection as a risk factor for shigellosis.

Authors:  J T Baer; D J Vugia; A L Reingold; T Aragon; F J Angulo; W Z Bradford
Journal:  Emerg Infect Dis       Date:  1999 Nov-Dec       Impact factor: 6.883

  6 in total
  9 in total

1.  Shigellosis in Subjects with Traveler's Diarrhea Versus Domestically Acquired Diarrhea: Implications for Antimicrobial Therapy and Human Immunodeficiency Virus Surveillance.

Authors:  Carlos Toro; Ana Arroyo; Ana Sarria; Nuria Iglesias; Ana Enríquez; Margarita Baquero; Concepción Ladrón de Guevara
Journal:  Am J Trop Med Hyg       Date:  2015-07-20       Impact factor: 2.345

2.  Evaluation of Shigella Species Azithromycin CLSI Epidemiological Cutoff Values and Macrolide Resistance Genes.

Authors:  Muna Salah; Issa Shtayeh; Raed Ghneim; Randa Al-Qass; Ali Sabateen; Hiyam Marzouqa; Musa Hindiyeh
Journal:  J Clin Microbiol       Date:  2019-03-28       Impact factor: 5.948

3.  Azithromycin and Ciprofloxacin Treatment Outcomes During an Outbreak of Multidrug-Resistant Shigella sonnei Infections in a Retirement Community-Vermont, 2018.

Authors:  Radhika Gharpure; Cindy R Friedman; Veronica Fialkowski; Jennifer P Collins; Jonathan Strysko; Zachary A Marsh; Jessica C Chen; Elizabeth H Meservey; Azizat A Adediran; Morgan N Schroeder; Ashutosh Wadhwa; Kathleen E Fullerton; Louise Francois Watkins
Journal:  Clin Infect Dis       Date:  2022-02-11       Impact factor: 9.079

4.  Shigella flexneri with Ciprofloxacin Resistance and Reduced Azithromycin Susceptibility, Canada, 2015.

Authors:  Christiane Gaudreau; Pierre A Pilon; Gilbert Cornut; Xavier Marchand-Senecal; Sadjia Bekal
Journal:  Emerg Infect Dis       Date:  2016-11       Impact factor: 6.883

5.  Combination Therapy with TCM Preparation Kumu Injection and Azithromycin against Bacterial Infection and Inflammation: In Vitro and In Vivo.

Authors:  Meiyu Yu; Xuejing Gu; Yanzheng Qu; Fuyou Sun; Yanli Li; Feng Zhao; Hui Xu
Journal:  Evid Based Complement Alternat Med       Date:  2022-03-16       Impact factor: 2.629

6.  Hybrid genome assembly of Shigella sonnei reveals the novel finding of chromosomal integration of an IncFII plasmid carrying a mphA gene.

Authors:  Dhiviya Prabaa Muthuirulandi Sethuvel; Shalini Anandan; Dhivya Murugan; Kalaiarasi Asokan; Karthick Vasudevan; Jobin John Jacob; Kamini Walia; Joy Sarojini Michael; Balaji Veeraraghavan
Journal:  Access Microbiol       Date:  2020-12-09

7.  Notes from the field: Shigella with decreased susceptibility to azithromycin among men who have sex with men - United States, 2002-2013.

Authors:  Katherine E Heiman; Maria Karlsson; Julian Grass; Becca Howie; Robert D Kirkcaldy; Barbara Mahon; John T Brooks; Anna Bowen
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2014-02-14       Impact factor: 17.586

Review 8.  The importance of integrons for development and propagation of resistance in Shigella: the case of Latin America.

Authors:  Kenia Barrantes; Rosario Achí
Journal:  Braz J Microbiol       Date:  2016-07-26       Impact factor: 2.476

9.  Shigellosis Among Gay and Bisexual Men: A Qualitative Assessment to Examine Knowledge, Attitudes, and Practices.

Authors:  Elise Caruso; Eric R Wright; Ebony Townsend Respress; Steve L Evener; Kathleen Jacobson; Anna Bowen; Rachel Kachur; Amanda Garcia-Williams
Journal:  Sex Transm Dis       Date:  2020-09       Impact factor: 3.868

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.